A study at Rhode Island Hospital is aiming to use saliva as a way to identify early brain changes indicative of Alzheimer’s disease. The Alzheimer’s Disease and Memory Disorders Center at Rhode Island Hospital is recruiting participants for its ExosomeAD study. The multi-year collaboration between researchers at Rhode Island Hospital and Brown University is funded by a grant from the National Institutes on Aging. The study will use saliva testing that can potentially detect changes in the brain caused by the disease. The center is seeking participants aged 65 years or older. Saliva and blood samples will be collected annually for up to five years, and cognitive tests will be given each year. Contact the the center by calling (401) 444-0085 to learn more about the ExosomeAD study or to enroll.